Duloxetine for the treatment of fibromyalgia (Q34663934)

3 August 2017

title

Duloxetine for the treatment of fibromyalgia. (English)

1 reference

3 August 2017

0 references

Scott D Mist

1 reference

3 August 2017

Cheryl L Wright

1 reference

3 August 2017

Rebecca L Ross

series ordinal

1 reference

3 August 2017

Kim D Jones

series ordinal

1 reference

3 August 2017

publication date

1 September 2010

1 reference

Expert Review of Clinical Immunology

3 August 2017

published in

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

745-756

1 reference

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Duloxetine for treating painful neuropathy or chronic pain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Contribution of the local and referred pain from active myofascial trigger points in fibromyalgia syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Societal and patient burden of fibromyalgia syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Exercise interventions in fibromyalgia: clinical applications from the evidence

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Pharmacotherapy of fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Clinical manifestations and diagnosis of fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Effects of 2 physiotherapy programs on pain perception, muscular flexibility, and illness impact in women with fibromyalgia: a pilot study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Treatment-emergent mania/hypomania in unipolar patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

A randomized controlled trial of acupuncture added to usual treatment for fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

The effectiveness of hydrotherapy in the management of fibromyalgia syndrome: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Opioids for chronic pain: molecular and genomic basis of actions and adverse effects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Selective serotonin reuptake inhibitors: measurement of effect on platelet function

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Decreased central mu-opioid receptor availability in fibromyalgia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Fibromyalgia: update on mechanisms and management

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Growth hormone perturbations in fibromyalgia: a review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Acupuncture for fibromyalgia--a systematic review of randomized clinical trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

The relationship between antidepressant prescription rates and rate of early adolescent suicide

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Complementary and alternative medical therapies in fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

From the gate to the neuromatrix

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss

7 July 2018

1 reference

Pain catastrophizing and neural responses to pain among persons with fibromyalgia

21 January 2018

1 reference

Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity

21 January 2018

1 reference

Pain, psychological variables, sleep quality, and natural killer cell activity in midlife women with and without fibromyalgia

21 January 2018

1 reference

Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism

21 January 2018

1 reference

New strategies in evaluation of therapeutic efficacy in fibromyalgia syndrome

21 January 2018

1 reference

Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study

21 January 2018

1 reference

Transcranial DC stimulation coupled with TENS for the treatment of chronic pain: a preliminary study

21 January 2018

1 reference

A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia

21 January 2018

1 reference

Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain

21 January 2018

1 reference

Changes in salivary cortisol and corticosteroid receptor-alpha mRNA expression following a 3-week multidisciplinary treatment program in patients with fibromyalgia

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

21 January 2018

1 reference

Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain

21 January 2018

1 reference

Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial

21 January 2018

1 reference

Fibromyalgia symptoms relieved by flupirtine: an open-label case series.

21 January 2018

1 reference

Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens

21 January 2018

1 reference

Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor

21 January 2018

1 reference

Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers

21 January 2018

1 reference

Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation

21 January 2018

1 reference

Pharmacokinetics of duloxetine in breast milk and plasma of healthy postpartum women

21 January 2018

1 reference

A retrospective pooled analysis of duloxetine safety in 23,983 subjects

21 January 2018

1 reference

Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects

21 January 2018

1 reference

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

21 January 2018

1 reference

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

21 January 2018

1 reference

Duloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials

21 January 2018

1 reference

Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.

21 January 2018

1 reference

Pain response profile of patients with fibromyalgia treated with duloxetine

21 January 2018

1 reference

Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins

21 January 2018

1 reference

A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia

21 January 2018

1 reference

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

The Relationship Between Antidepressant Prescription Rates and Rate of Early Adolescent Suicide

21 January 2018

1 reference

The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Decreased sleep spindles and spindle activity in midlife women with fibromyalgia and pain

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3056054

Work and disability status of persons with fibromyalgia

26 October 2018

1 reference

12 December 2020

Windup leads to characteristics of central sensitization

1 reference

12 December 2020

Duloxetine (cymbalta) for fibromyalgia

1 reference

12 December 2020

An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies

1 reference

12 December 2020

The economic burden of fibromyalgia: comparative analysis with rheumatoid arthritis

1 reference

12 December 2020

Dopamine D(1) and D(2) receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test

1 reference

12 December 2020

Lessons learned combining N-of-1 trials to assess fibromyalgia therapies

1 reference

12 December 2020

The risk of suicide with selective serotonin reuptake inhibitors in the elderly

1 reference

12 December 2020

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial

1 reference

12 December 2020

Management of patients with fibromyalgia using biofeedback: a randomized control trial

1 reference

12 December 2020

Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects

1 reference

12 December 2020

The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1586/ECI.10.64

1 reference

3 August 2017

1 reference

3 August 2017

1 reference